FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a
Read MoreAugust 09, 2023 7 min read Source/Disclosures Disclosures: Diedrich and Teherani report no relevant financial disclosures. Healio could not confirm
Read MoreEvery weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a
Read MoreAugust 10, 2023 2 min read Source/Disclosures Disclosures: Harris reports no relevant financial disclosures. Please see the study for all
Read MoreAugust 10, 2023 2 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read MoreLiselotte Sabroe | Afp | Getty Images Novo Nordisk on Thursday said it will acquire Inversago Pharma, a privately held
Read MoreAugust 11, 2023 2 min read Source/Disclosures Published by: Disclosures: Von Moltke is employed by Seres Therapeutics. Please see the
Read MoreAugust 12, 2023 2 min read Source/Disclosures Published by: Disclosures: Klompas reports receiving institutional grant funding from AHRQ, CDC, and
Read MoreMerck & Co. Inc.’s Januvia brand medication, used to treat Type 2 diabetes. Daniel Acker | Bloomberg | Getty Images
Read MoreAugust 11, 2023 2 min read Source/Disclosures Disclosures: Becerra, Houry and Murthy report no relevant financial disclosures. ADD TOPIC TO
Read More